Category: Uterine cancer

Home / Uterine cancer

Categories

Sacituzumab govitecan receives fast approval from the FDA for advanced urothelial cancer

August 2021: Sacituzumab govitecan (Trodelvy, Immunomedics Inc.) was given accelerated approval by the Food and Drug Administration for patients with locally advanced or metastatic urothelial cancer (...

Scan the code